Skip to content

Life Sciences

Our Life Sciences group is a multi-disciplinary team of more than 90 lawyers drawn from across our global network.

We have a reputation for far-sighted advice to some of the world’s leading life science companies and are described as "an efficient and client-oriented team" in Chambers Global 2010 Life Sciences edition.

Our support for pharmaceuticals, biotech, medical devices, nursing homes and other healthcare-related companies, as well as financial institutions operating in the sector, covers the spectrum: mergers and acquisitions (M&A), commercial transactions, including licensing and collaborations, intellectual property (IP) protection and patent disputes, capital markets and finance, regulatory and private equity.

Our international network enables us to deploy the skills of market-leading experts in a number of jurisdictions and we are well placed to advise on cross-border work, both contentious and non-contentious.

News & insights

News: 12 FEBRUARY 2021

Allen & Overy conseille Biogroup dans le cadre de deux émissions d'obligations high yield et de la conclusion d’un contrat de crédit senior

Biogroup, groupe indépendant de laboratoires de biologie médicale présent sur le marché français et belge, a réalisé le 9 février 2021, par l’intermédiaire de ses deux principales filiales, une…

Lire la suite

Publications: 19 NOVEMBER 2020

La cour de justice de l’UE confirme que le cannabidiol n’est pas un stupéfiant et qu’un Etat membre ne peut en interdire la commercialisation

Aujourd'hui, le 19 novembre 2020, la Cour de justice de l'Union européenne (CJUE) a rendu sa décision très attendue dans l'affaire C-663/18 (Kanavape) jugeant qu’un Etat membre ne peut interdire la…

Lire la suite

Life Sciences Hub

Legal and regulatory developments in the Life Sciences sector.

Contenu recommandé